Wells Fargo’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Other funds holding WGS
CM
CC
AIM
VCM
ZDA
Wells Fargo's WGS Position: Q1 2026 in Review
Wells Fargo reduced its GeneDx Holdings (WGS) stake by 29% in Q1 2026, selling an estimated $1.15M and leaving 30,300 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #3287.
Wells Fargo first reported a position in WGS in Q1 2021 and has held it in 21 quarters since. The position peaked at $5.58M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.
- Wells Fargo held 30,300 shares of GeneDx Holdings worth $1.95M as of Q1 2026.
- Wells Fargo sold 12,611 GeneDx Holdings shares in Q1 2026, an estimated $1.15M.
- GeneDx Holdings made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3287 holding.
- Wells Fargo first reported a position in GeneDx Holdings in Q1 2021 and has held it in 21 quarters since.
- Wells Fargo's GeneDx Holdings position peaked at $5.58M in Q4 2025.
- 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.